What one share of HeartSciences holds
We are a healthcare information technology company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”). Our first commercial product is MyoVista Insights™, a cloud-native, vendor- and device-agnostic ECG management platform designed to modernize ECG workflows and enable scalable deployment of AI-ECG capabilities across healthcare systems.
HeartSciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $0.00 |
|---|---|
| Profit | −$3.18 |
| Cash and investments | $0.01 |
| Debt | $0.95 |
| Book value | −$0.52 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.43 | −$145.48 | $0.06 | −$109.86 | — | −$182.19 |
| 2023 | $0.06 | −$79.92 | $0.23 | −$72.85 | — | $2.27 |
| 2024 | $0.05 | −$18.74 | $0.18 | −$17.40 | — | $10.81 |
| 2025 | $0.00 | −$9.34 | $0.00 | −$7.90 | $0.00 | $0.18 |
| 2026 | $0.00 | −$3.48 | $0.00 | −$2.83 | $0.00 | $0.07 |
Common questions about HeartSciences
How much does one share of HeartSciences earn?
Over the last 12 months, HeartSciences lost $3.18 for each share on $0.00 of sales.
Does HeartSciences pay a dividend?
HeartSciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is HeartSciences’s book value per share?
HeartSciences’s book value is negative (−$0.52 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of July 31, 2026.
How much cash and debt does each share of HeartSciences have?
Each share of HeartSciences has $0.01 of cash and investments and $0.95 of debt, as of July 31, 2026.
Has HeartSciences bought back shares?
HeartSciences’s share count rose about 7811% from 2022 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.